FDA Inspection
UCB Pharma S.A.UCB Pharma S.A. – FDA Inspection, Sep 11, 2015
Record Details
This FDA Inspection record concerns UCB Pharma S.A., with an inspection on September 11, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- UCB Pharma S.A.
- Inspection Date
- September 11, 2015
- Product Type
- Drugs
View Company Profile
ID · 4a28d1df-64ef-4aa7-b8ac-3606f8d6b0de
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 946302
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of UCB Pharma S.A.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2026 | Not classified | Office of Inspections and Investigations | Compliance: Devices |
| February 1, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 21, 2023 | Not classified | Office of Inspections and Investigations | |
| November 25, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 27, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for UCB Pharma S.A.
- FDA Inspection 1323186 - 2026-06-04
- FDA Inspection 1247808 - 2024-02-01
- FDA Inspection 1208307 - 2023-04-21
- FDA Inspection 1170317 - 2021-11-25
- FDA Inspection 1013309 - 2017-01-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.